207 related articles for article (PubMed ID: 10582698)
1. Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells.
Ambs S; Dennis S; Fairman J; Wright M; Papkoff J
Cancer Res; 1999 Nov; 59(22):5773-7. PubMed ID: 10582698
[TBL] [Abstract][Full Text] [Related]
2. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
[TBL] [Abstract][Full Text] [Related]
3. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
[TBL] [Abstract][Full Text] [Related]
4. Low dose adjuvant angiostatin decreases hepatic micrometastasis in murine ocular melanoma model.
Yang H; Akor C; Dithmar S; Grossniklaus HE
Mol Vis; 2004 Dec; 10():987-95. PubMed ID: 15623988
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
[TBL] [Abstract][Full Text] [Related]
6. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
[TBL] [Abstract][Full Text] [Related]
7. Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy.
Rodolfo M; Catò EM; Soldati S; Ceruti R; Asioli M; Scanziani E; Vezzoni P; Parmiani G; Sacco MG
Cancer Gene Ther; 2001 Jul; 8(7):491-6. PubMed ID: 11498770
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice.
Gyorffy S; Palmer K; Gauldie J
Am J Pathol; 2001 Sep; 159(3):1137-47. PubMed ID: 11549607
[TBL] [Abstract][Full Text] [Related]
9. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
[TBL] [Abstract][Full Text] [Related]
10. Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis.
Gorrin-Rivas MJ; Arii S; Furutani M; Mizumoto M; Mori A; Hanaki K; Maeda M; Furuyama H; Kondo Y; Imamura M
Clin Cancer Res; 2000 May; 6(5):1647-54. PubMed ID: 10815882
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
Gorski DH; Mauceri HJ; Salloum RM; Gately S; Hellman S; Beckett MA; Sukhatme VP; Soff GA; Kufe DW; Weichselbaum RR
Cancer Res; 1998 Dec; 58(24):5686-9. PubMed ID: 9865723
[TBL] [Abstract][Full Text] [Related]
12. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer.
Matsuda KM; Madoiwa S; Hasumi Y; Kanazawa T; Saga Y; Kume A; Mano H; Ozawa K; Matsuda M
Cancer Gene Ther; 2000 Apr; 7(4):589-96. PubMed ID: 10811477
[TBL] [Abstract][Full Text] [Related]
13. Long-term expression of angiostatin suppresses metastatic liver cancer in mice.
Xu R; Sun X; Tse LY; Li H; Chan PC; Xu S; Xiao W; Kung HF; Krissansen GW; Fan ST
Hepatology; 2003 Jun; 37(6):1451-60. PubMed ID: 12774025
[TBL] [Abstract][Full Text] [Related]
14. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Tanaka T; Cao Y; Folkman J; Fine HA
Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
[TBL] [Abstract][Full Text] [Related]
15. Angiostatin suppresses malignant glioma growth in vivo.
Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
[TBL] [Abstract][Full Text] [Related]
16. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
O'Reilly MS
EXS; 1997; 79():273-94. PubMed ID: 9002223
[TBL] [Abstract][Full Text] [Related]
17. Mouse macrophage metalloelastase generates angiostatin from plasminogen and suppresses tumor angiogenesis in murine colon cancer.
Xu Z; Shi H; Li Q; Mei Q; Bao J; Shen Y; Xu J
Oncol Rep; 2008 Jul; 20(1):81-8. PubMed ID: 18575722
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
19. Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells.
Indraccolo S; Morini M; Gola E; Carrozzino F; Habeler W; Minghelli S; Santi L; Chieco-Bianchi L; Cao Y; Albini A; Noonan DM
Cancer Res; 2001 Jul; 61(14):5441-6. PubMed ID: 11454689
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]